Pharmeuropa

European Pharmacopoeia technical guide for elaboration of monographs 2 ed. Pharmeuropa, Special Issue, November 1996. [Pg.341]

Charton E 1997) Establishment and use of biological reference substances of the European Pharmacopoiea. Pharmeuropa 9 327-330. [Pg.193]

Daas AGJ and Miller JHMcB (1997) Content limits in the European Pharmacopoeia (Part i). How to define limits in monographs and how to use them. Pharmeuropa 9 148-156. [Pg.193]

International Flarmonisation (1995) Harmonisation policies of the Pharmacopoeial discussion group (July 1995). Pharmeuropa 7 4r3-42o. [Pg.193]

Rose U (1996) The establishment and use of reference substances of the European Pharmacopoeia. Pharmeuropa 8 455-464. [Pg.195]

Sandrin J, Daas AGJ and Charton E (1997) Establishment of reference substances for the microbiological assay of antibiotics. Pharmeuropa 9 327-330. [Pg.195]

The Biological Standardization Programme (1996) Pharmeuropa Bio 1 1-5. Speiser JM, Raut-mann G, Coune C, eds. Council of Europe, Strasbourg. [Pg.195]

Pharmeuropa is available by annual subscription in English and Frendi from the Council of Europe and is published four times per year. Like the U SP s Pharmacopoeial Forum it contains draft monographs for comment, official announcements, scientific notes and the contents to the fascicles issued by the EP for EP website see Table 8.4. [Pg.274]

Alterations to the content of the EP are first presented for public review in the quarterly, PharmEuropa, which was... [Pg.70]

FIGURE 2 Reference electropherogram of erythropoietin. (Reprinted with permission from Pharmeuropa I I (2) (1999) 415.)... [Pg.161]

European Directorate for the Quality of Medicines. (2007). State of work of international harmonisation. Pharmeuropa 19(1), 161. [Pg.165]

Novatchev, N., and Holzgrabe, U. (2002). Comparison of the suitability of capillary electrophoresis and thin-layer chromatography for determination of impurities In amino acids. Pharmeuropa 14(4), 640-647. [Pg.165]

Bristow, A., and Charton, E. (1999). Assessment of the suitability of a capillary zone electrophoresis method for determining isoform distribution of erythropoietin. Pharmeuropa 11(2), 290—300. [Pg.165]

Miller, J. H. McB., and Rose, U. (2001). Comparison of chiral liquid chromatographic methods and capillary electrophoresis, separation of the enantiomers of ephedrine hydrochloride. Pharmeuropa 13(1), 3-7. [Pg.165]

Weber, C., Matingen, S., and Holzgrabe, U. (2005). Batch variability of bacitracin HPLC versus MEKC. Pharmeuropa Sci. Notes 1, 47—52. [Pg.165]

Hermentin, P. (2006). Isoforms number - a new tool to evaluate the quality of erythropoietin. Pharmeuropa Sci. Notes 2006-1, 37—40. [Pg.257]

Harmonization proposals do not have official status. The work of the PDG is finished at Stage 5B. The progress of the harmonization projects can and should be verified in the most recent number of Pharmacopeial Forum, Japanese Pharmaco-poeial Forum, and Pharmeuropa. For standards in force in USP24-NF19, see also the latest Supplement or Interim Revision Annoimcement. [Pg.83]

Proceedings of Interpharmacopeial Open Conference on Standards for Biotechnology-derived Products, Pharmeuropa (Special Edition), 1993. [Pg.91]

Stage 3 Pubhcation of fhe draft text in the forum of each pharmacopoeia Pharmeuropa (Ph Eur), Japanese Pharmacopoeial Forum (JP) and Pharmacopoeial Forum (USP) Comments received and consohdated Preparation of a second draft text ( Stage 3 draft )... [Pg.560]

Pharmaceutical compendia issued in countries or regions that detail procedures to test the quality of pharmaceuticals (US Pharmacopia, Pharmeuropa, Japanese Pharmacopia). [Pg.34]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...